Vertex Ventures HC Leads Series B in Bicycle Therapeutics
Posted on 06/02/2017
On June 1, 2017, Bicycle Therapeutics, a U.K.-based biotherapeutics company, raised £40 million in Series B funding. Leading the investment round was Vertex Ventures HC, a venture unit of Temasek Holdings. Other new investors in the round include the Longwood Fund (a healthcare venture capital firm) and Cambridge Innovation Capital. Existing investors Novartis Venture Fund, […]
- Alternatives
- Asia
- Bicycle Therapeutics
- Cambridge Innovation Capital
- cancer
- Europe
- healthcare
- Temasek Holdings
- UK
- Venture Capital
